X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (596) 596
Publication (58) 58
Conference Proceeding (10) 10
Book Chapter (2) 2
Book / eBook (1) 1
Book Review (1) 1
Data Set (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (320) 320
index medicus (233) 233
hematology (206) 206
female (172) 172
male (170) 170
adult (161) 161
middle aged (156) 156
transplantation (146) 146
oncology (113) 113
stem cells (92) 92
aged (91) 91
hematopoietic stem cells (88) 88
transplantation, homologous (88) 88
immunology (78) 78
adolescent (65) 65
leukemia (64) 64
treatment outcome (57) 57
hematopoietic stem cell transplantation (55) 55
bone marrow (53) 53
hematology, oncology and palliative medicine (50) 50
analysis (48) 48
cancer (48) 48
care and treatment (46) 46
versus-host-disease (43) 43
bone-marrow-transplantation (42) 42
animals (41) 41
recurrence (41) 41
stem cell transplantation (41) 41
young adult (41) 41
cell biology (40) 40
acute myeloid-leukemia (39) 39
therapy (39) 39
research (38) 38
chemotherapy (37) 37
retrospective studies (36) 36
hematopoietic stem cell transplantation - adverse effects (35) 35
leukemia, myeloid, acute - therapy (35) 35
stem-cells (35) 35
survival rate (35) 35
disease-free survival (34) 34
mice (34) 34
stem-cell transplantation (34) 34
transplantation conditioning - methods (34) 34
bone-marrow (33) 33
cells, cultured (33) 33
prognosis (33) 33
survival (33) 33
hematopoietic stem cell transplantation - methods (32) 32
immunotherapy (32) 32
medicine, research & experimental (32) 32
progenitor cells (32) 32
risk factors (32) 32
survival analysis (32) 32
hematopoietic stem cells - cytology (30) 30
t cells (30) 30
expression (29) 29
leukemia, myeloid, acute - mortality (29) 29
mesenchymal stromal cells - cytology (28) 28
acute myeloid leukemia (26) 26
article (26) 26
graft vs host disease - prevention & control (26) 26
in-vitro (26) 26
aml (25) 25
relapse (25) 25
remission induction (25) 25
risk (25) 25
abridged index medicus (24) 24
advanced basic science (24) 24
cell & tissue engineering (24) 24
child (24) 24
flow cytometry (24) 24
prospective studies (24) 24
acute myelogenous leukemia (23) 23
mortality (23) 23
allogeneic stem cell transplantation (22) 22
blood (22) 22
follow-up studies (22) 22
leukemia, myeloid, acute - genetics (22) 22
acute disease (21) 21
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
cell proliferation (21) 21
differentiation (21) 21
health aspects (21) 21
hematopoietic stem cells - metabolism (21) 21
lymphocytes (21) 21
mutation (20) 20
patient outcomes (20) 20
biotechnology & applied microbiology (19) 19
dendritic cells (19) 19
mesenchymal stromal cells (19) 19
myelodysplastic syndrome (19) 19
myelodysplastic syndromes (19) 19
transplantation conditioning (19) 19
bone-marrow transplantation (18) 18
coculture techniques (18) 18
genetic aspects (18) 18
myelodysplastic syndromes - therapy (18) 18
peripheral-blood (18) 18
time factors (18) 18
allogeneic transplantation (17) 17
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 9, pp. 855 - 864
Journal Article